Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness.
Saved in:
| Title: | Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness. |
|---|---|
| Authors: | Woods BS; Centre for Health Economics, University of York, York, UK. Electronic address: beth.woods@york.ac.uk., Sideris E; Centre for Health Economics, University of York, York, UK., Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Gannon MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Alzouebi M; Weston Park Hospital, Sheffield, UK., Attard G; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK., Birtle AJ; Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK., Brock S; Dorset Cancer Centre, Poole Hospital NHS Foundation Trust, Poole, UK., Cathomas R; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; Kantonsspital Graubünden, Chur, Switzerland., Chakraborti PR; Royal Derby Hospital, Derby, UK., Cook A; Gloucestershire Oncology Centre, Cheltenham, UK., Cross WR; Department of Urology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Dearnaley DP; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK., Gale J; Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth, UK., Gibbs S; Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK., Graham JD; Beacon Centre, Musgrove Park Hospital, Taunton, UK., Hughes R; Mount Vernon Group, Mount Vernon Hospital, Northwood, UK., Jones RJ; University of Glasgow, UK., Laing R; St Luke's Cancer Centre, Royal Surrey NHS Trust, Guildford, UK., Mason MD; School of Medicine, Cardiff University, Cardiff, UK., Matheson D; University of Wolverhampton, Wolverhampton, UK., McLaren DB; Department of Oncology, Western General Hospital, Edinburgh, UK., Millman R; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., O'Sullivan JM; Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK., Parikh O; Department of Oncology, East Lancashire Hospitals NHS Trust, Burnley, UK., Parker CC; The Royal Marsden NHS Foundation Trust, London, UK., Peedell C; South Tees NHS Foundation Trust, Middlesbrough, UK., Protheroe A; Department of Oncology, Churchill Hospital, Oxford, UK., Ritchie AWS; Gloucestershire Royal Hospital Foundation Trust, Gloucester, UK., Robinson A; Sussex Cancer Centre, Royal Sussex County Hospital, Brighton, UK., Russell JM; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK; Forth Valley Royal Hospital, Larbert, UK., Simms MS; Hull and East Yorkshire Hospitals NHS Trust, Hull, UK., Srihari NN; Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury, UK., Srinivasan R; Royal Devon & Exeter NHS Foundation Trust, Exeter, UK., Staffurth JN; Velindre Cancer Centre, Cardiff and School of Medicine, Cardiff University, Cardiff, UK., Sundar S; University of Nottingham, Nottingham, UK., Thalmann GN; Department of Urology, University Hospital Bern, Bern, Switzerland., Tolan S; Clatterbridge Cancer Centre, Birkenhead, UK., Tran ATH; The Christie NHS Foundation Trust, Manchester, UK., Tsang D; Southend and Basildon Hospitals, Southend, UK., Wagstaff J; Swansea University College of Medicine, Swansea, UK., James ND; Queen Elizabeth Hospital, Edgbaston, Birmingham, UK., Sculpher MJ; Centre for Health Economics, University of York, York, UK. |
| Source: | European urology oncology [Eur Urol Oncol] 2018 Dec; Vol. 1 (6), pp. 449-458. Date of Electronic Publication: 2018 Sep 14. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31158087 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Woods+BS%22">Woods BS</searchLink>; Centre for Health Economics, University of York, York, UK. Electronic address: beth.woods@york.ac.uk.<br /><searchLink fieldCode="AU" term="%22Sideris+E%22">Sideris E</searchLink>; Centre for Health Economics, University of York, York, UK.<br /><searchLink fieldCode="AU" term="%22Sydes+MR%22">Sydes MR</searchLink>; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Gannon+MR%22">Gannon MR</searchLink>; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Parmar+MKB%22">Parmar MKB</searchLink>; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Alzouebi+M%22">Alzouebi M</searchLink>; Weston Park Hospital, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Attard+G%22">Attard G</searchLink>; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Birtle+AJ%22">Birtle AJ</searchLink>; Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK.<br /><searchLink fieldCode="AU" term="%22Brock+S%22">Brock S</searchLink>; Dorset Cancer Centre, Poole Hospital NHS Foundation Trust, Poole, UK.<br /><searchLink fieldCode="AU" term="%22Cathomas+R%22">Cathomas R</searchLink>; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; Kantonsspital Graubünden, Chur, Switzerland.<br /><searchLink fieldCode="AU" term="%22Chakraborti+PR%22">Chakraborti PR</searchLink>; Royal Derby Hospital, Derby, UK.<br /><searchLink fieldCode="AU" term="%22Cook+A%22">Cook A</searchLink>; Gloucestershire Oncology Centre, Cheltenham, UK.<br /><searchLink fieldCode="AU" term="%22Cross+WR%22">Cross WR</searchLink>; Department of Urology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Dearnaley+DP%22">Dearnaley DP</searchLink>; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Gale+J%22">Gale J</searchLink>; Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth, UK.<br /><searchLink fieldCode="AU" term="%22Gibbs+S%22">Gibbs S</searchLink>; Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK.<br /><searchLink fieldCode="AU" term="%22Graham+JD%22">Graham JD</searchLink>; Beacon Centre, Musgrove Park Hospital, Taunton, UK.<br /><searchLink fieldCode="AU" term="%22Hughes+R%22">Hughes R</searchLink>; Mount Vernon Group, Mount Vernon Hospital, Northwood, UK.<br /><searchLink fieldCode="AU" term="%22Jones+RJ%22">Jones RJ</searchLink>; University of Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Laing+R%22">Laing R</searchLink>; St Luke's Cancer Centre, Royal Surrey NHS Trust, Guildford, UK.<br /><searchLink fieldCode="AU" term="%22Mason+MD%22">Mason MD</searchLink>; School of Medicine, Cardiff University, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Matheson+D%22">Matheson D</searchLink>; University of Wolverhampton, Wolverhampton, UK.<br /><searchLink fieldCode="AU" term="%22McLaren+DB%22">McLaren DB</searchLink>; Department of Oncology, Western General Hospital, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Millman+R%22">Millman R</searchLink>; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22O'Sullivan+JM%22">O'Sullivan JM</searchLink>; Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK.<br /><searchLink fieldCode="AU" term="%22Parikh+O%22">Parikh O</searchLink>; Department of Oncology, East Lancashire Hospitals NHS Trust, Burnley, UK.<br /><searchLink fieldCode="AU" term="%22Parker+CC%22">Parker CC</searchLink>; The Royal Marsden NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Peedell+C%22">Peedell C</searchLink>; South Tees NHS Foundation Trust, Middlesbrough, UK.<br /><searchLink fieldCode="AU" term="%22Protheroe+A%22">Protheroe A</searchLink>; Department of Oncology, Churchill Hospital, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Ritchie+AWS%22">Ritchie AWS</searchLink>; Gloucestershire Royal Hospital Foundation Trust, Gloucester, UK.<br /><searchLink fieldCode="AU" term="%22Robinson+A%22">Robinson A</searchLink>; Sussex Cancer Centre, Royal Sussex County Hospital, Brighton, UK.<br /><searchLink fieldCode="AU" term="%22Russell+JM%22">Russell JM</searchLink>; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK; Forth Valley Royal Hospital, Larbert, UK.<br /><searchLink fieldCode="AU" term="%22Simms+MS%22">Simms MS</searchLink>; Hull and East Yorkshire Hospitals NHS Trust, Hull, UK.<br /><searchLink fieldCode="AU" term="%22Srihari+NN%22">Srihari NN</searchLink>; Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury, UK.<br /><searchLink fieldCode="AU" term="%22Srinivasan+R%22">Srinivasan R</searchLink>; Royal Devon & Exeter NHS Foundation Trust, Exeter, UK.<br /><searchLink fieldCode="AU" term="%22Staffurth+JN%22">Staffurth JN</searchLink>; Velindre Cancer Centre, Cardiff and School of Medicine, Cardiff University, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Sundar+S%22">Sundar S</searchLink>; University of Nottingham, Nottingham, UK.<br /><searchLink fieldCode="AU" term="%22Thalmann+GN%22">Thalmann GN</searchLink>; Department of Urology, University Hospital Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tolan+S%22">Tolan S</searchLink>; Clatterbridge Cancer Centre, Birkenhead, UK.<br /><searchLink fieldCode="AU" term="%22Tran+ATH%22">Tran ATH</searchLink>; The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Tsang+D%22">Tsang D</searchLink>; Southend and Basildon Hospitals, Southend, UK.<br /><searchLink fieldCode="AU" term="%22Wagstaff+J%22">Wagstaff J</searchLink>; Swansea University College of Medicine, Swansea, UK.<br /><searchLink fieldCode="AU" term="%22James+ND%22">James ND</searchLink>; Queen Elizabeth Hospital, Edgbaston, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Sculpher+MJ%22">Sculpher MJ</searchLink>; Centre for Health Economics, University of York, York, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101724904%22">European urology oncology</searchLink> [Eur Urol Oncol] 2018 Dec; Vol. 1 (6), pp. 449-458. <i>Date of Electronic Publication: </i>2018 Sep 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101724904 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2588-9311 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225889311%22">25889311 </searchLink><i>NLM ISO Abbreviation: </i>Eur Urol Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31158087 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.euo.2018.06.004 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 449 Titles: – TitleFull: Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Woods BS – PersonEntity: Name: NameFull: Sideris E – PersonEntity: Name: NameFull: Sydes MR – PersonEntity: Name: NameFull: Gannon MR – PersonEntity: Name: NameFull: Parmar MKB – PersonEntity: Name: NameFull: Alzouebi M – PersonEntity: Name: NameFull: Attard G – PersonEntity: Name: NameFull: Birtle AJ – PersonEntity: Name: NameFull: Brock S – PersonEntity: Name: NameFull: Cathomas R – PersonEntity: Name: NameFull: Chakraborti PR – PersonEntity: Name: NameFull: Cook A – PersonEntity: Name: NameFull: Cross WR – PersonEntity: Name: NameFull: Dearnaley DP – PersonEntity: Name: NameFull: Gale J – PersonEntity: Name: NameFull: Gibbs S – PersonEntity: Name: NameFull: Graham JD – PersonEntity: Name: NameFull: Hughes R – PersonEntity: Name: NameFull: Jones RJ – PersonEntity: Name: NameFull: Laing R – PersonEntity: Name: NameFull: Mason MD – PersonEntity: Name: NameFull: Matheson D – PersonEntity: Name: NameFull: McLaren DB – PersonEntity: Name: NameFull: Millman R – PersonEntity: Name: NameFull: O'Sullivan JM – PersonEntity: Name: NameFull: Parikh O – PersonEntity: Name: NameFull: Parker CC – PersonEntity: Name: NameFull: Peedell C – PersonEntity: Name: NameFull: Protheroe A – PersonEntity: Name: NameFull: Ritchie AWS – PersonEntity: Name: NameFull: Robinson A – PersonEntity: Name: NameFull: Russell JM – PersonEntity: Name: NameFull: Simms MS – PersonEntity: Name: NameFull: Srihari NN – PersonEntity: Name: NameFull: Srinivasan R – PersonEntity: Name: NameFull: Staffurth JN – PersonEntity: Name: NameFull: Sundar S – PersonEntity: Name: NameFull: Thalmann GN – PersonEntity: Name: NameFull: Tolan S – PersonEntity: Name: NameFull: Tran ATH – PersonEntity: Name: NameFull: Tsang D – PersonEntity: Name: NameFull: Wagstaff J – PersonEntity: Name: NameFull: James ND – PersonEntity: Name: NameFull: Sculpher MJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2018 Dec Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 2588-9311 Numbering: – Type: volume Value: 1 – Type: issue Value: 6 Titles: – TitleFull: European urology oncology Type: main |
| ResultId | 1 |